These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1105 related items for PubMed ID: 8946863

  • 1. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
    Look KY, Brunetto VL, Clarke-Pearson DL, Averette HE, Major FJ, Alvarez RD, Homesley HD, Zaino RJ.
    Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
    [Abstract] [Full Text] [Related]

  • 2. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy.
    Harrison TA, Sevin BU, Koechli O, Nguyen HN, Averette HE, Penalver M, Donato DM, Nadji M.
    Gynecol Oncol; 1993 Sep; 50(3):310-5. PubMed ID: 8406193
    [Abstract] [Full Text] [Related]

  • 3. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
    dos Reis R, Frumovitz M, Milam MR, Capp E, Sun CC, Coleman RL, Ramirez PT.
    Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
    [Abstract] [Full Text] [Related]

  • 4. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
    Shimada M, Kigawa J, Takahashi M, Minagawa Y, Okada M, Kanamori Y, Itamochi H, Oishi T, Iba T, Terakawa N.
    Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
    [Abstract] [Full Text] [Related]

  • 5. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
    Yasuda S, Kojima A, Maeno Y, Oki N, Miyahara Y, Sudo T, Takekida S, Yamaguchi S, Nishimura R.
    Kobe J Med Sci; 2006 Jun; 52(1-2):9-15. PubMed ID: 16547424
    [Abstract] [Full Text] [Related]

  • 6. A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study.
    Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI, Zaino RJ.
    Int J Radiat Oncol Biol Phys; 2006 May 01; 65(1):169-76. PubMed ID: 16427212
    [Abstract] [Full Text] [Related]

  • 7. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M, Graf AH, Lax S, Forstner R, Dandachi N, Haas J, Pickel H, Reich O, Staudach A, Winter R.
    Gynecol Oncol; 2001 Jul 01; 82(1):11-6. PubMed ID: 11426955
    [Abstract] [Full Text] [Related]

  • 8. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
    Chen L, Lü WG, Xie X, Chen HZ, Yu H, Ni XH.
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr 01; 40(4):239-42. PubMed ID: 15924669
    [Abstract] [Full Text] [Related]

  • 9. Changes in the demographics and perioperative care of stage IA(2)/IB(1) cervical cancer over the past 16 years.
    Covens A, Rosen B, Murphy J, Laframboise S, DePetrillo AD, Lickrish G, Colgan T, Chapman W, Shaw P.
    Gynecol Oncol; 2001 May 01; 81(2):133-7. PubMed ID: 11330939
    [Abstract] [Full Text] [Related]

  • 10. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
    Zhang WH, Wu LY, Bai P, Li SM, Zhang R, Li B, Sun JH, Wu AR.
    Zhonghua Zhong Liu Za Zhi; 2004 Aug 01; 26(8):490-2. PubMed ID: 15555341
    [Abstract] [Full Text] [Related]

  • 11. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Nakanishi T, Ishikawa H, Suzuki Y, Inoue T, Nakamura S, Kuzuya K.
    Gynecol Oncol; 2000 Nov 01; 79(2):289-93. PubMed ID: 11063659
    [Abstract] [Full Text] [Related]

  • 12. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynecologic Oncology Group/Southwest Oncology Group/Radiation Therapy Oncology Group trial.
    Monk BJ, Wang J, Im S, Stock RJ, Peters WA, Liu PY, Barrett RJ, Berek JS, Souhami L, Grigsby PW, Gordon W, Alberts DS, Gynecologic Oncology Group, Southwest Oncology Group, Radiation Therapy Oncology Group.
    Gynecol Oncol; 2005 Mar 01; 96(3):721-8. PubMed ID: 15721417
    [Abstract] [Full Text] [Related]

  • 13. Radical hysterectomy for recurrent carcinoma of the uterine cervix after radiotherapy.
    Coleman RL, Keeney ED, Freedman RS, Burke TW, Eifel PJ, Rutledge FN.
    Gynecol Oncol; 1994 Oct 01; 55(1):29-35. PubMed ID: 7959262
    [Abstract] [Full Text] [Related]

  • 14. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.
    Macdonald OK, Chen J, Dodson M, Lee CM, Gaffney DK.
    Am J Clin Oncol; 2009 Aug 01; 32(4):411-6. PubMed ID: 19451800
    [Abstract] [Full Text] [Related]

  • 15. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT, Hsu JC, Liu WS, Wang AY, Huang WT, Chang TH, Pi CP, Huang CY, Huang CC, Chou PH, Chen TH.
    Eur J Cancer Care (Engl); 2008 Mar 01; 17(2):174-81. PubMed ID: 18302655
    [Abstract] [Full Text] [Related]

  • 16. Total laparoscopic radical hysterectomy (type II-III) with pelvic lymphadenectomy in early invasive cervical cancer.
    Gil-Moreno A, Puig O, Pérez-Benavente MA, Díaz B, Vergés R, De la Torre J, Martínez-Palones JM, Xercavins J.
    J Minim Invasive Gynecol; 2005 Mar 01; 12(2):113-20. PubMed ID: 15904613
    [Abstract] [Full Text] [Related]

  • 17. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer.
    Suprasert P, Srisomboon J, Charoenkwan K, Siriaree S, Cheewakriangkrai C, Kietpeerakool C, Phongnarisorn C, Sae-Teng J.
    J Obstet Gynaecol; 2010 Apr 01; 30(3):294-8. PubMed ID: 20373935
    [Abstract] [Full Text] [Related]

  • 18. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study.
    Benedetti-Panici P, Maneschi F, D'Andrea G, Cutillo G, Rabitti C, Congiu M, Coronetta F, Capelli A.
    Cancer; 2000 May 15; 88(10):2267-74. PubMed ID: 10820348
    [Abstract] [Full Text] [Related]

  • 19. Surgical pathologic factors that predict recurrence in stage IB and IIA cervical carcinoma patients with negative pelvic lymph nodes.
    Samlal RA, van der Velden J, Ten Kate FJ, Schilthuis MS, Hart AA, Lammes FB.
    Cancer; 1997 Oct 01; 80(7):1234-40. PubMed ID: 9317173
    [Abstract] [Full Text] [Related]

  • 20. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol.
    Reich O, Tamussino K, Lahousen M, Pickel H, Haas J, Winter R.
    Gynecol Oncol; 2000 Mar 01; 76(3):331-5. PubMed ID: 10684706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 56.